Identification and Validation of a Novel Inflammatory Response-Related Gene Signature for the Prognosis of Colon Cancer

References

• Hofseth LJ, Hebert JR, Chanda A, et al. Early-onset colorectal cancer: initial clues and current views. Nat Rev Gastroenterol Hepatol. 2020;17(6):352–364.
   PubMed Web of Science ®Google Scholar
• Carethers JM, Jung BH. Genetics and genetic biomarkers in sporadic colorectal cancer. Gastroenterology. 2015;149(5):1177–1190.e3. doi:10.1053/j.gastro.2015.06.047
   PubMed Web of Science ®Google Scholar
• Okugawa Y, Grady WM, Goel A. Epigenetic alterations in colorectal cancer: emerging biomarkers. Gastroenterology. 2015;149(5):584.
   Web of Science ®Google Scholar
• Niu G, Deng L, Zhang X, et al. GABRD promotes progression and predicts poor prognosis in colorectal cancer. Open Med. 2020;15(1):1172–1183. doi:10.1515/med-2020-0128
   Web of Science ®Google Scholar
• Zhang L, Jiang X, Li Y, et al. Clinical correlation of Wnt2 and COL8A1 with colon adenocarcinoma prognosis. Front Oncol. 2020;10:1504. doi:10.3389/fonc.2020.01504
   PubMed Web of Science ®Google Scholar
• Liu J, Jiang C, Xu C, et al. Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma. Cancer Cell Int. 2021;21(1):101. doi:10.1186/s12935-021-01795-1
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Qian S, Golubnitschaja O, Zhan X. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles. EPMA J. 2019;10(4):365–381. doi:10.1007/s13167-019-00194-x
   PubMed Web of Science ®Google Scholar
• Neagu M, Constantin C, Caruntu C, Dumitru C, Surcel M, Zurac S. Inflammation: a key process in skin tumorigenesis. Oncol Lett. 2019;17(5):4068–4084.
   PubMed Web of Science ®Google Scholar
• Wu Y, Antony S, Meitzler JL, Doroshow JH. Molecular mechanisms underlying chronic inflammation-associated cancers. Cancer Lett. 2014;345(2):164–173. doi:10.1016/j.canlet.2013.08.014
   PubMed Web of Science ®Google Scholar
• Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–e503. doi:10.1016/S1470-2045(14)70263-3
   PubMed Web of Science ®Google Scholar
• Galizia G, Lieto E, Zamboli A, et al. Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis. Surgery. 2015;158(1):112–120. doi:10.1016/j.surg.2015.02.006
   PubMed Web of Science ®Google Scholar
• Malik HZ, Prasad KR, Halazun KJ, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg. 2007;246(5):806–814. doi:10.1097/SLA.0b013e318142d964
   PubMed Web of Science ®Google Scholar
• Turner N, Wong H-L, Templeton A, et al. Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria. Int j Cancer. 2016;138(3):671–678. doi:10.1002/ijc.29805
   PubMed Web of Science ®Google Scholar
• Liang Y, Su Q, Wu X. Identification and validation of a novel six-gene prognostic signature of stem cell characteristic in colon cancer. Front Oncol. 2020;10:571655. doi:10.3389/fonc.2020.571655
   PubMed Web of Science ®Google Scholar
• Newman AM, Steen CB, Liu CL, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773–782. doi:10.1038/s41587-019-0114-2
   PubMed Web of Science ®Google Scholar
• Puccini A, Lenz H-J. Colorectal cancer in 2017: practice-changing updates in the adjuvant and metastatic setting. Nat Rev Clin Oncol. 2018;15(2):77–78. doi:10.1038/nrclinonc.2017.185
   PubMed Web of Science ®Google Scholar
• Sveen A, Kopetz S, Lothe RA. Biomarker-guided therapy for colorectal cancer: strength in complexity. Nat Rev Clin Oncol. 2020;17(1):11–32.
   PubMed Web of Science ®Google Scholar
• Lech G, Słotwiński R, Słodkowski M, Krasnodębski IW. Colorectal cancer tumour markers and biomarkers: recent therapeutic advances. World j Gastroenterol. 2016;22(5):1745–1755. doi:10.3748/wjg.v22.i5.1745
   PubMed Web of Science ®Google Scholar
• Rabbenou W, Ullman TA. Risk of colon cancer and recommended surveillance strategies in patients with ulcerative colitis. Gastroenterol Clin North Am. 2020;49(4):791–807. doi:10.1016/j.gtc.2020.08.005
   PubMed Web of Science ®Google Scholar
• Nasef NA, Mehta S. Role of inflammation in pathophysiology of colonic disease: an update. Int J Mol Sci. 2020;21(13):4748. doi:10.3390/ijms21134748
   PubMed Web of Science ®Google Scholar
• Aalkjaer C, Boedtkjer E, Choi I, Lee S. Cation-coupled bicarbonate transporters. Compr Physiol. 2014;4(4):1605–1637.
   PubMed Web of Science ®Google Scholar
• McIntyre A, Hulikova A, Ledaki I, et al. Disrupting hypoxia-induced bicarbonate transport acidifies tumor cells and suppresses tumor growth. Cancer Res. 2016;76(13):3744–3755. doi:10.1158/0008-5472.CAN-15-1862
   PubMed Web of Science ®Google Scholar
• Yang H, Lu Y, Lan W, Huang B, Lin J. Down-regulated solute carrier family 4 member 4 predicts poor progression in colorectal cancer. J Cancer. 2020;11(12):3675–3684. doi:10.7150/jca.36696
   PubMed Web of Science ®Google Scholar
• Wallrapp A, Riesenfeld SJ, Burkett PR, et al. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. Nature. 2017;549(7672):351–356. doi:10.1038/nature24029
   PubMed Web of Science ®Google Scholar
• Misawa K, Mima M, Satoshi Y, et al. Neuropeptide receptor genes GHSR and NMUR1 are candidate epigenetic biomarkers and predictors for surgically treated patients with oropharyngeal cancer. Sci Rep. 2020;10(1):1007. doi:10.1038/s41598-020-57920-z
   PubMed Web of Science ®Google Scholar
• Jia R, Li Z, Liang W, et al. Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis. World J Surg Oncol. 2020;18(1):268. doi:10.1186/s12957-020-02042-z
   PubMed Web of Science ®Google Scholar
• Böckelman C, Beilmann-Lehtonen I, Kaprio T, et al. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer. BMC Cancer. 2018;18(1):679. doi:10.1186/s12885-018-4589-x
   PubMedGoogle Scholar
• Zaravinos A, Lambrou GI, Boulalas I, Delakas D, Spandidos DA. Identification of common differentially expressed genes in urinary bladder cancer. PLoS One. 2011;6(4):e18135. doi:10.1371/journal.pone.0018135
   PubMed Web of Science ®Google Scholar
• Obata K, Shimo T, Okui T, et al. Tachykinin receptor 3 distribution in human oral squamous cell carcinoma. Anticancer Res. 2016;36(12):6335–6341. doi:10.21873/anticanres.11230
   PubMed Web of Science ®Google Scholar
• Murray PJ. On macrophage diversity and inflammatory metabolic timers. Nat Rev Immunol. 2020;20(2):89–90. doi:10.1038/s41577-019-0260-2
   PubMed Web of Science ®Google Scholar
• DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19(6):369–382. doi:10.1038/s41577-019-0127-6
   PubMed Web of Science ®Google Scholar
• Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 2019;30(1):36–50. doi:10.1016/j.cmet.2019.06.001
   PubMed Web of Science ®Google Scholar
• Pond KW, Doubrovinski K, Thorne CA. Wnt/β-catenin signaling in tissue self-organization. Genes. 2020;11(8):939. doi:10.3390/genes11080939
   PubMed Web of Science ®Google Scholar
• Zhong Z, Virshup DM. Wnt signaling and drug resistance in cancer. Mol Pharmacol. 2020;97(2):72–89. doi:10.1124/mol.119.117978
   PubMed Web of Science ®Google Scholar
• Shen P, Pichler M, Chen M, Calin GA, Ling H. To Wnt or lose: the missing non-coding linc in colorectal cancer. Int J Mol Sci. 2017;18(9):2003. doi:10.3390/ijms18092003
   PubMed Web of Science ®Google Scholar
• Cheriyamundath S, Ben-Ze’ev A. Wnt/β-catenin target genes in colon cancer metastasis: the special case of L1CAM. Cancers. 2020;12(11):3444. doi:10.3390/cancers12113444
   PubMed Web of Science ®Google Scholar
• Dawson JC, Serrels A, Stupack DG, Schlaepfer DD, Frame MC. Targeting FAK in anticancer combination therapies. Nat Rev Cancer. 2021;21(5):313–324. doi:10.1038/s41568-021-00340-6
   PubMed Web of Science ®Google Scholar
• Urciuoli E, Peruzzi B. Involvement of the FAK network in pathologies related to altered mechanotransduction. Int J Mol Sci. 2020;21(24):9426. doi:10.3390/ijms21249426
   PubMed Web of Science ®Google Scholar
• Ying H, Lin F, Ding R, Wang W, Hong W. Extracellular vesicles carrying miR-193a derived from mesenchymal stem cells impede cell proliferation, migration and invasion of colon cancer by downregulating FAK. Exp Cell Res. 2020;394(2):112144. doi:10.1016/j.yexcr.2020.112144
   PubMed Web of Science ®Google Scholar
• Hao H-F, Takaoka M, Bao X-H, et al. Oral administration of FAK inhibitor TAE226 inhibits the progression of peritoneal dissemination of colorectal cancer. Biochem Biophys Res Commun. 2012;423(4):744–749. doi:10.1016/j.bbrc.2012.06.030
   PubMed Web of Science ®Google Scholar
• Derynck R, Turley SJ, Akhurst RJ. TGFβ biology in cancer progression and immunotherapy. Nat Rev Clin Oncol. 2021;18(1):9–35.
   PubMed Web of Science ®Google Scholar
• Batlle E, Massagué J. Transforming growth factor-β signaling in immunity and cancer. Immunity. 2019;50(4):924–940. doi:10.1016/j.immuni.2019.03.024
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330–337. doi:10.1038/nature11252
   PubMed Web of Science ®Google Scholar
• Marisa L, de Reyniès A, Duval A, et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. 2013;10(5):e1001453. doi:10.1371/journal.pmed.1001453
   PubMed Web of Science ®Google Scholar
• Liu X, Yu W, Liang C, et al. INHBA is a prognostic predictor for patients with colon adenocarcinoma. BMC Cancer. 2020;20(1):305. doi:10.1186/s12885-020-06743-2
   PubMed Web of Science ®Google Scholar
• Cao Y, Jiao N, Sun T, et al. CXCL11 correlates with antitumor immunity and an improved prognosis in colon cancer. Front Cell Dev Biol. 2021;9:646252. doi:10.3389/fcell.2021.646252
   PubMed Web of Science ®Google Scholar
• Zhang Q, Feng Z, Zhang Y, Shi S, Zhang Y, Ren S. Identification and verification of a 17 immune-related gene pair prognostic signature for colon cancer. Biomed Res Int. 2021;2021:6057948. doi:10.1155/2021/6057948
   PubMed Web of Science ®Google Scholar
• Lv Y, Wang X, Ren Y, Fu X, Li T, Jiang Q. Construction of an immune-related signature with prognostic value for colon cancer. PeerJ. 2021;9:e10812. doi:10.7717/peerj.10812
   PubMed Web of Science ®Google Scholar
• Luo J, Liu P, Wang L, et al. Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis. BMC Cancer. 2020;20(1):1071. doi:10.1186/s12885-020-07532-7
   PubMed Web of Science ®Google Scholar